Skip to main content
NCBI home page
Pilot and Feasibility Studies logoLink to Pilot and Feasibility Studies
. 2016 Sep 12;2:55. doi: 10.1186/s40814-016-0095-6

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

M P Snee 1, L McParland 2, F Collinson 2, C M Lowe 2, A Striha 2, D R Baldwin 3, B Naidu 4, D Sebag-Montefiore 1,6, W M Gregory 2, J Bestall 5, J Hewison 5, S Hinsley 2, K N Franks 1,✉
PMCID: PMC5154043  PMID: 27976752

Erratum

After publication of the original article [1], it came to the authors’ attention that a source of funding had been inadvertently omitted from the Acknowledgements section; support from Yorkshire Cancer Research should have mentioned originally.

Footnotes

The online version of the original article can be found under doi:10.1186/s40814-016-0046-2.

Reference

  • 1.Snee MP, McParland L, Collinson F, Lowe CM, Striha A, Baldwin DR, et al. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot Feasability Studies. 2016;2:5. doi: 10.1186/s40814-016-0046-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pilot and Feasibility Studies are provided here courtesy of BMC

RESOURCES